CANADA’S COMMERCIALIZATION PLATFORM FOR NOVEL THERAPIES TARGETING CANCER STEM CELLS

Trillium Therapeutics Inc. (TSX: TR) (Formerly Stem Cell Therapeutics Corp.), a Toronto-based biopharmaceutical development company, is Canada’s only public company dedicated to advancing cancer stem cell discoveries into novel and innovative cancer therapies. Building on over half a century of leading groundbreaking Canadian stem cell research, we are supported by established links to multiple Toronto academic institutes and oncology treatment centres that represent one of the world’s most acclaimed cancer research hubs. A new Trillium Therapeutics website will be launched in the near future.

OUR COMPANY

Learn about the people and principles that are driving our company towards success.

OUR TECHNOLOGY

Discover some of the exciting technologies that we are developing.

INVESTORS

Realize how we are dedicated to providing long-term shareholder value.

©2014 Trillium Therapeutics Inc. - All rights reserved